Invasive Mould Infection clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18 years and up

    The purpose of this study is to determine if EL219 is safe and effective compared to liposomal amphotericin B (LAmB) or voricanozole for early treatment of invasive mould infections

    at UC Davis

Last updated: